Abstract
BackgroundBiologic agents can help achieve low disease activity or remission in patients with rheumatoid arthritis (RA) who do not respond adequately to therapy with one or two conventional synthetic disease...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
